Wan Fang Lau
Bristol-Myers Squibb
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Wan Fang Lau.
Bioorganic & Medicinal Chemistry Letters | 1997
Spencer D. Kimball; Jagabandhu Das; Wan Fang Lau; Steven E. Hall; Wen-Ching Han
Abstract A series of boropeptides have previously been described by Kettner et al. to be potent thrombin inhibitors. DuP 714 is a representative of this class of compounds with a K i = 0.040 nM, but this inhibitor has undesireable side effects. New and selective boronic acid thrombin inhibitors have been developed by replacing the guanidine of the boroarginine side chain with various heterocycles ranging in size and basicity.
Bioorganic & Medicinal Chemistry Letters | 1997
Toni Kline; Ellen Sieber-McMaster; Wan Fang Lau; Sesha Natarajan
Abstract Molecular modeling studies suggest that the phenothiazine nucleus, embedded in a peptide via attachments at the 3- and 7-positions, may be a possible surrogate for the α-carbon backbone of five residue turns in a variety of proteins. The synthesis of the orthogonally-protected Fmoc 3-aminoethyl-7-carboxyethyl-10-methylphenothiazine ( 1 ) is described.
Archive | 1993
Spencer D. Kimball; Jagabandhu Das; Wan Fang Lau
Archive | 1994
Spencer D. Kimball; Jagabandhu Das; Wan Fang Lau
Archive | 1996
Jagabandhu Das; Spencer D. Kimball; Wan Fang Lau
Archive | 1994
Spencer D. Kimball; Steven E. Hall; Wan Fang Lau
Archive | 1994
Spencer D. Kimball; Jagabandhu Das; Wan Fang Lau
Archive | 1995
Spencer D. Kimball; Jagabandhu Das; Wan Fang Lau
Archive | 1994
Spencer D. Kimball; Jagabandhu Das; Wan Fang Lau
Archive | 1994
Spencer D. Kimball; Jagabandhu Das; Wan Fang Lau